Loading...
XNYS
ASIX
Market cap422mUSD
Dec 04, Last price  
15.73USD
1D
-0.82%
1Q
-25.77%
Jan 2017
-28.95%
IPO
-18.07%
Name

AdvanSix Inc

Chart & Performance

D1W1MN
XNYS:ASIX chart
P/E
9.57
P/S
0.28
EPS
1.64
Div Yield, %
3.05%
Shrs. gr., 5y
-1.16%
Rev. gr., 5y
3.18%
Revenues
1.52b
-1.05%
1,766,586,0001,790,372,0001,329,409,0001,191,524,0001,475,194,0001,514,984,0001,297,393,0001,157,917,0001,684,625,0001,945,640,0001,533,599,0001,517,557,000
Net income
44m
-19.18%
118,746,00083,858,00063,776,00034,147,000146,699,00066,244,00041,347,00046,077,000139,791,000171,886,00054,623,00044,149,000
CFO
135m
+15.20%
119,995,000188,424,000101,536,000113,740,000134,607,000173,385,000120,385,000111,847,000218,849,000273,601,000117,550,000135,413,000
Dividend
Aug 13, 20240.16 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
IPO date
Sep 14, 2016
Employees
1,458
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT